Literature DB >> 19639670

Countries race to contain resistance to key antimalarial.

Udani Samarasekera.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19639670     DOI： 10.1016/s0140-6736(09)61349-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.

Authors:  Gundula Min-Oo; Anny Fortin; Jean-François Poulin; Philippe Gros
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

Review 2.  Artemisinin resistance: current status and scenarios for containment.

Authors:  Arjen M Dondorp; Shunmay Yeung; Lisa White; Chea Nguon; Nicholas P J Day; Duong Socheat; Lorenz von Seidlein
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

3.  Case Report: Cambodian National Malaria Surveillance Program Detection of Plasmodium knowlesi.

Authors:  Christina Yek; Sreyngim Lay; Jennifer A Bohl; Somnang Man; Sophana Chea; Chanthap Lon; Vida Ahyong; Cristina M Tato; Joseph L DeRisi; Siv Sovannaroth; Jessica E Manning
Journal:  Am J Trop Med Hyg       Date:  2022-07-13       Impact factor: 3.707

Review 4.  Isoprenoid biosynthesis in Plasmodium falciparum.

Authors:  Ann M Guggisberg; Rachel E Amthor; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2014-09-12

Review 5.  A growing global network's role in outbreak response: AFHSC-GEIS 2008-2009.

Authors:  Matthew C Johns; Ronald L Burke; Kelly G Vest; Mark Fukuda; Julie A Pavlin; Sanjaya K Shrestha; David C Schnabel; Steven Tobias; Jeffrey A Tjaden; Joel M Montgomery; Dennis J Faix; Mark R Duffy; Michael J Cooper; Jose L Sanchez; David L Blazes; Sonam Wangchuk; Tandin Dorji; Robert Gibbons; Sopon Iamsirithaworn; Jason Richardson; Rome Buathong; Richard Jarman; In-Kyu Yoon; Geeta Shakya; Victor Ofula; Rodney Coldren; Wallace Bulimo; Rosemary Sang; Duke Omariba; Beryl Obura; Dennis Mwala; Matthew Kasper; Gary Brice; Maya Williams; Chad Yasuda; Robert V Barthel; Guillermo Pimentel; Chris Meyers; Peter Kammerer; Darcie E Baynes; David Metzgar; Anthony Hawksworth; Patrick Blair; Melody Ellorin; Robert Coon; Victor Macintosh; Kristen Burwell; Elizabeth Macias; Thomas Palys; Kurt Jerke
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

6.  Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts.

Authors:  Johanna M Porter-Kelley; Joann Cofie; Sophonie Jean; Mark E Brooks; Mia Lassiter; Dc Ghislaine Mayer
Journal:  Infect Drug Resist       Date:  2010-08-09       Impact factor: 4.003

7.  "Souls of the ancestor that knock us out" and other tales. A qualitative study to identify demand-side factors influencing malaria case management in Cambodia.

Authors:  Kathryn A O'Connell; Ghazaleh Samandari; Sochea Phok; Mean Phou; Lek Dysoley; Shunmay Yeung; Henrietta Allen; Megan Littrell
Journal:  Malar J       Date:  2012-10-05       Impact factor: 2.979

8.  Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.

Authors:  Eva Maria Staehli Hodel; Monia Guidi; Boris Zanolari; Thomas Mercier; Socheat Duong; Abdunoor M Kabanywanyi; Frédéric Ariey; Thierry Buclin; Hans-Peter Beck; Laurent A Decosterd; Piero Olliaro; Blaise Genton; Chantal Csajka
Journal:  Malar J       Date:  2013-07-10       Impact factor: 2.979

9.  Biological activities of Croton palanostigma Klotzsch.

Authors:  Eduardo Ferreira Mota; Diele Magno Rosario; Andreza Socorro Silva Veiga; Davi Do Socorro Barros Brasil; Fernando Tobias Silveira; Maria Fâni Dolabela
Journal:  Pharmacogn Mag       Date:  2015 Jul-Sep       Impact factor: 1.085

10.  A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.

Authors:  James S McCarthy; Thomas Rückle; Elhadj Djeriou; Cathy Cantalloube; Daniel Ter-Minassian; Mark Baker; Peter O'Rourke; Paul Griffin; Louise Marquart; Rob Hooft van Huijsduijnen; Jörg J Möhrle
Journal:  Malar J       Date:  2016-09-13       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.